Literature DB >> 11863370

BHLHB4 is a bHLH transcriptional regulator in pancreas and brain that marks the dimesencephalic boundary.

Debra E Bramblett1, Neal G Copeland, Nancy A Jenkins, Ming-Jer Tsai.   

Abstract

We have cloned a basic helix-loop-helix (bHLH) factor gene, Bhlhb4, from a mouse beta-cell line. Fluorescence in situ hybridization (FISH) and genetic mapping place Bhlhb4 at the telomeric end of mouse chromosome 2 (H3-H4), syntenic to human chromosome 20q13. Based on phylogenetic analysis, BHLHB4 belongs to a new subgroup of bHLH factors including at least four previously identified mouse bHLH factors: BHLHB5, MIST1, OLIG1, OLIG2, and OLIG3. In the developing nervous system, Bhlhb4 was found to mark the dimesencephalic boundary, suggesting that Bhlhb4 may have a role in diencephalic regionalization. In the pancreas, Bhlhb4 is expressed in a transient fashion that suggests a role in the pancreatic endocrine cell lineage. Transfection experiments show that BHLHB4 can repress transcriptional activation mediated through the pancreatic beta-cell specific insulin promoter enhancer RIPE3. Together, these data suggest that BHLHB4 may modulate the expression of genes required for the differentiation and/or maintenance of pancreatic and neuronal cell types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11863370     DOI: 10.1006/geno.2002.6708

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  20 in total

1.  Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assembly.

Authors:  Sarah E Ross; Alejandra E McCord; Cynthia Jung; Denize Atan; Stephanie I Mok; Martin Hemberg; Tae-Kyung Kim; John Salogiannis; Linda Hu; Sonia Cohen; Yingxi Lin; Dana Harrar; Roderick R McInnes; Michael E Greenberg
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

2.  Requirement for Bhlhb5 in the specification of amacrine and cone bipolar subtypes in mouse retina.

Authors:  Liang Feng; Xiaoling Xie; Pushkar S Joshi; Zhiyong Yang; Koji Shibasaki; Robert L Chow; Lin Gan
Journal:  Development       Date:  2006-11-08       Impact factor: 6.868

3.  Transcription factor Gbx2 acts cell-nonautonomously to regulate the formation of lineage-restriction boundaries of the thalamus.

Authors:  Li Chen; Qiuxia Guo; James Y H Li
Journal:  Development       Date:  2009-03-11       Impact factor: 6.868

4.  Bhlhb5 is required for the subtype development of retinal amacrine and bipolar cells in mice.

Authors:  Liang Huang; Fang Hu; Liang Feng; Xiong-Jian Luo; Guoqing Liang; Xiang-Yun Zeng; Jing-Lin Yi; Lin Gan
Journal:  Dev Dyn       Date:  2013-11-13       Impact factor: 3.780

5.  Neuronatin, a downstream target of BETA2/NeuroD1 in the pancreas, is involved in glucose-mediated insulin secretion.

Authors:  Khoi Chu; Ming-Jer Tsai
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

6.  Aberrant expression of genes necessary for neuronal development and Notch signaling in an epileptic mind bomb zebrafish.

Authors:  Gabriela A Hortopan; Scott C Baraban
Journal:  Dev Dyn       Date:  2011-06-17       Impact factor: 3.780

7.  From retinal circuitry to eye diseases--in memory of Henk Spekreijse.

Authors:  Samuel M Wu
Journal:  Vision Res       Date:  2008-11-12       Impact factor: 1.886

Review 8.  Evolution of the CNS myelin gene regulatory program.

Authors:  Huiliang Li; William D Richardson
Journal:  Brain Res       Date:  2015-10-22       Impact factor: 3.252

9.  Analysis of the transcriptomes downstream of Eyeless and the Hedgehog, Decapentaplegic and Notch signaling pathways in Drosophila melanogaster.

Authors:  Landry E Nfonsam; Carlos Cano; Joann Mudge; Faye D Schilkey; Jennifer Curtiss
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

10.  Regulation of locomotion and motoneuron trajectory selection and targeting by the Drosophila homolog of Olig family transcription factors.

Authors:  Justine Oyallon; Holger Apitz; Irene Miguel-Aliaga; Katarina Timofeev; Lauren Ferreira; Iris Salecker
Journal:  Dev Biol       Date:  2012-07-14       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.